Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.775 USD | -0.19% | +0.91% | -6.03% |
May. 09 | Cantor Fitzgerald Adjusts LifeMD's Price Target to $15 From $13, Keeps Overweight Rating | MT |
May. 08 | Transcript : LifeMD, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.03% | 329M | |
+6.58% | 33.25B | |
+20.58% | 7.96B | |
+34.25% | 4.25B | |
-31.06% | 2.67B | |
-15.25% | 1.48B | |
-25.17% | 1.28B | |
-29.79% | 1.2B | |
+11.26% | 999M | |
-36.79% | 902M |
- Stock Market
- Equities
- LFMD Stock
- News LifeMD, Inc.
- B. Riley Raises LifeMD's PT to $7 From $3.50 on Increased Conviction for Durable Growth, Enhanced EBITDA; Keeps Buy Rating